Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
AstraZeneca
Accenture
Harvard Business School
Fish and Richardson
Farmers Insurance
McKesson
Queensland Health
US Department of Justice

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062087

« Back to Dashboard

NDA 062087 describes ERYTHROMYCIN ESTOLATE, which is a drug marketed by Barr, Ivax Sub Teva Pharms, Watson Labs, Alpharma Us Pharms, G And W Labs Inc, and Life Labs, and is included in seven NDAs. Additional details are available on the ERYTHROMYCIN ESTOLATE profile page.

The generic ingredient in ERYTHROMYCIN ESTOLATE is erythromycin estolate. There are one hundred and one drug master file entries for this compound. Additional details are available on the erythromycin estolate profile page.
Summary for 062087
Tradename:ERYTHROMYCIN ESTOLATE
Applicant:Watson Labs
Ingredient:erythromycin estolate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 250MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
AstraZeneca
Deloitte
US Army
Accenture
McKesson
Julphar
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot